Study of Household Influenza prophylaxis Effect of Long-acting anti-influenza Drug

Trial Profile

Study of Household Influenza prophylaxis Effect of Long-acting anti-influenza Drug

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Aug 2012

At a glance

  • Drugs Laninamivir (Primary)
  • Indications Influenza A virus infections; Influenza B virus infections; Influenza virus infections
  • Focus Registrational; Therapeutic Use
  • Acronyms SHIELD
  • Most Recent Events

    • 22 Aug 2012 Results published in a Biota Holdings Media Release.
    • 22 Aug 2012 Primary endpoint 'Infection-rate' has been met.
    • 27 Jun 2011 Preliminary results indicate that the primary endpoint may not be met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top